Edwards Lifesciences v Meril (CFI, 29 September 2023)
| Date | 29 September 2023 |
|---|---|
| Court | CFI |
| Division | Munich (DE) Local Division |
| Type of action | Infringement Action |
| Case number(s) | UPC_CFI_15/2023 |
| Registry reference | ORD_576853/2023 · UPC_CFI_15/2023 |
| Parties | Edwards Lifesciences Corporation v. Meril GmbH |
Official decision (PDF) · UPC registry entry
Case timeline
- 1 August 2023 : Edwards Lifesciences v Meril (CFI, 1 August 2023) App_557291/2023 · UPC_CFI_15/2023
- 10 August 2023 : Meril v Edwards Lifesciences (CFI, 10 August 2023) ORD_557466/2023 · UPC_CFI_15/2023
- 23 August 2023 : Edwards Lifesciences v Meril (CFI, 23 August 2023) ORD_562614/2023 · UPC_CFI15/2023
Dhenne Avocats represents claimants and defendants in European patent disputes before the Unified Patent Court, including the Paris divisions.
Dhenne Avocats · 10 October 2026
Our analysis
Summary
By order of 29 September 2023 (ORD_576853/2023, UPC_CFI_15/2023), the judge-rapporteur of the Munich Local Division deferred to the main proceedings the preliminary objection lodged by Meril GmbH and Meril Life Sciences in Edwards Lifesciences’ infringement action on EP 3 646 825, declined to stay the proceedings for the time being, dismissed the application for security for costs and requested the assignment of a technically qualified judge. The judge-rapporteur already gives his view on jurisdiction over acts before 1 June 2023.
Question
Should the jurisdictional challenges, the request for a stay and a CJEU referral, and the application for security for costs against a US-based claimant be decided at this stage?
Decision
The objection, wrongly filed in the statement of defence workflow, was not held inadmissible given that the system was new (Rule 4.1 RoP). The concern about extension to future ratifying states was hypothetical. The argument excluding acts before 1 June 2023 was considered legally wrong in light of Arts 3(c) and 32(1)(a) UPCA. Since the claim targets the teaching of the patent as a whole, the Munich division has competence over Meril GmbH, based in Bonn, and over its Indian parent under the second sentence of Art. 33(1)(b) UPCA, given their commercial relationship. A stay and a referral are not among the grounds listed in Rule 19.1 RoP and will be reconsidered in the main proceedings. Security for costs (Art. 69(4) UPCA, Rule 158.1 RoP) requires a showing of financial weakness or particular difficulty of enforcement. Mere uncertainty about recognition in the United States is not enough.
Key points for practice
- A claimant’s seat outside the EU does not on its own justify security for costs.
- Practical point: a preliminary objection must be filed in its own electronic workflow, separate from the statement of defence.
Provisions applied
- Agreement on a Unified Patent Court
- Arts 3(c), 8(5), 32(1)(a), 33(1)(b) and 69(4)
- Rules of Procedure
- Rules 4.1, 19.1, 20.2 and 158.1
Prepared by Dhenne Avocats from the official decision, consulted on 10 October 2026. The database is updated every week, on Friday. Only the official text is authoritative.
Decisions in the same proceedings
Going further
Lexicon: Patent infringement action.
Publications by Matthieu Dhenne: Pleading the Long Arm: What a UPC Statement of Claim Must Carry Beyond Jurisdiction (Kluwer Patent Blog).
Source and translations
- Official source
- Unified Patent Court registry link recorded in the record
- Original language
- not recorded
- Translation available
- no translation recorded the firm’s French record is a summary, not a translation
- Date checked
- not recorded
Follow this case
Proceedings, related decisions, appeals, parties and patents as recorded in the registry and in the Dhenne Avocats corpus. Each link states its source.
Parties
- claimantEdwards Lifesciences Corporation41 decisions in the corpusFollow this party
- defendantMeril GmbH45 decisions in the corpusFollow this party
Decisions in the same proceedings and documented appeals
- 1 August 2023 Edwards Lifesciences v Meril (CFI, 1 August 2023) Infringement Action · UPC_CFI_15/2023
- 10 August 2023 Meril v Edwards Lifesciences (CFI, 10 August 2023) Infringement Action · UPC_CFI_15/2023
Le juge rapporteur proroge au 4 septembre 2023 le délai d'exception préliminaire de Meril GmbH, à titre exceptionnel et avec l'accord d'Edwards, congés et charge de travail n'étant pas des motifs suffisants.
- 23 August 2023 Edwards Lifesciences v Meril (CFI, 23 August 2023) Infringement Action · UPC_CFI_15/2023
Le juge rapporteur proroge au 2 novembre 2023 le délai de défense de Meril GmbH, à titre exceptionnel et avec l'accord d'Edwards, l'alignement des délais n'étant pas en soi un motif de prorogation.
- 29 September 2023 Edwards Lifesciences v Meril (CFI, 29 September 2023) Infringement Action · UPC_CFI_15/2023
- 5 May 2025 Meril Life Sciences v SWAT Medical (CoA, 5 May 2025) Decision By Default · appeal, first-instance number cited in the decision
La cour d’appel annule l’ordonnance d’accès et rejette la demande : un membre du public non représenté ne peut obtenir l’accès de la règle 262.1(b), et aucun frais n’est alloué dans cette procédure.
What the record states
- Nature of the act
- Infringement Action
- Outcome (Dhenne Avocats summary)
- Le juge rapporteur joint l'exception préliminaire au fond, refuse en l'état le sursis, rejette la demande de garantie des frais visant une demanderesse américaine et demande l'adjonction d'un juge technicien.
- Appeal
- An appeal is documented in the corpus (see above).
- Instance
- First-instance decision, whether it has become final is not recorded.
Patents mentioned
EP 3 646 825mentioned in: Dhenne Avocats analysis Follow this patent
Related decisions cited in the analyses
- Edwards Lifesciences v Meril (CFI, 23 August 2023) cited in this record
- Meril v Edwards Lifesciences (CFI, 10 August 2023) cited in this record
- Edwards Lifesciences v Meril (CFI, 1 August 2023) cited in this record
- Nixu FL IP Protection v Infoblox (CFI, 10 June 2026) cites this decision
- Headwater Research v Motorola Mobility (CFI, ORD_18004/2025, 3 July 2025) cites this decision
- Headwater Research v Motorola Mobility (CFI, ORD_18005/2025, 3 July 2025) cites this decision
- Headwater Research v Motorola Mobility (CFI, ORD_63889/2024, 20 June 2025) cites this decision
- Headwater Research v Motorola Mobility (CFI, ORD_69211/2024, 20 June 2025) cites this decision
- Genevant Sciences v Moderna (CFI, 23 May 2025) cites this decision
- GXD-Bio v Myriad International (CFI, 26 November 2024) cites this decision
- HEWLETT-PACKARD DEVELOPMENT v LAMA FRANCE (CFI, 13 November 2024) cites this decision
- SodaStream Industries v Aarke (CFI, 6 September 2024) cites this decision
- SodaStream Industries v Aarke (CFI, 5 August 2024) cites this decision
- Nokia Technology v Mala Technologies (CFI, 2 July 2024) cites this decision
- ICPillar v Arm (CFI, 21 May 2024) cites this decision
- Volkswagen v Network System Technologies (CFI, ORD_12231/2024, 23 April 2024) cites this decision
- Network System Technologies v Volkswagen (CFI, 23 April 2024) cites this decision
- Volkswagen v Network System Technologies (CFI, ORD_12484/2024, 23 April 2024) cites this decision
- Volkswagen v Network System Technologies (CFI, ORD_12483/2024, 23 April 2024) cites this decision
- Volkswagen v Network System Technologies (CFI, ORD_17417/2024, 23 April 2024) cites this decision
- SVF Holdco v ICPillar (CFI, 11 April 2024) cites this decision
- NanoString Technologies Europe v President and Fellows of Harvard College (CFI, 30 October 2023) cites this decision
Patents and standards
| Publication | Role in the dispute | Family | Standard and declaration | Pool | Sources |
|---|---|---|---|---|---|
EP 3 646 825A system comprising a prosthetic valve and a delivery catheter recorded proprietor: Edwards Lifesciences Corp | Mentioned in the analysis (role not qualified) Also mentioned in 32 other decision(s): Edwards Lifesciences v Meril Life Sciences (CFI, 15 November 2024) · Meril Italy v Edwards Lifesciences (CFI, 19 July 2024) · Meril v Edwards Lifesciences (CFI, 19 July 2024) · Meril Italy v Edwards Lifesciences (CoA, 25 November 2025) · Edwards Lifesciences v Sintec (CFI, 5 September 2025) · Meril Italy v SWAT Medical (CoA, 5 May 2025) · Meril v SWAT Medical (CoA, 5 May 2025) · Meril Life Sciences v SWAT Medical (CoA, 5 May 2025) | not recorded | not recorded | not recorded | Espacenet · European Patent Register existence and title of the publication checked on 30 October 2026 (Google Patents, Espacenet and Register links are not checked automatically) mentioned in: Dhenne Avocats analysis |
Receive an alert
Weekly summary of new records and substantive updates matching what you follow. Address confirmed by email, unsubscribe at any time, one email per week even where several of your follows match.